Carla Carnovale, Vera Battini, Claudia Santoro, Maria Pia Riccio, Sara Carucci, Maria Nobile, Pietro Formisano, Carmela Bravaccio, Alessandro Zuddas, Emilio Clementi, Marco Pozzi, Simone Pisano
OBJECTIVE: To summarize the available evidence on metabolic parameters indicating metabolic adverse effects and risk of metabolic syndrome in children and adolescents treated with antipsychotics, following a pre-specified protocol (PROSPERO ID 252336). METHOD: We searched PubMed, Embase and PsycINFO until May 14, 2021, to identify systematic reviews (SR), meta-analyses (MA) and network meta-analyses (NMA) examining symptoms associated to metabolic syndrome in patients <18 years of age who required treatment with oral antipsychotic drugs...
June 23, 2023: Journal of the American Academy of Child and Adolescent Psychiatry